Abate provides guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics. The Biotech Investor is the comprehensive, expert source for successful and intelligent investing in one of the twenty-first century's most promisi
| Title | : | The Biotech Investor: How to Profit from the Coming Boom in Biotechnology |
| Author | : | Tom Abate |
| Rating | : | 4.79 (442 Votes) |
| Asin | : | 0805075089 |
| Format Type | : | Paperback |
| Number of Pages | : | 304Pages |
| Publish Date | : | 2014-4-29 |
| Language | : | English |
Abate provides guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics.
The Biotech Investor is the comprehensive, expert source for successful and intelligent investing in one of the twenty-first century's most promising industries..
"Tom Abate's reporting on biotechnology has always been ahead of the times. He shares strategies for• tracking the effect of breaking news and the NASDAQ• anticipating drug trial announcements and FDA approvals• assessing the potential market, patent rights, and distribution deals for a drugHe looks beyond medicine to biotech-related opportunities in everything from agriculture to jean manufacturing to software development. The Biotech Investor tackles the brave new world of stem cells, genomics, and clones and comes up a winner." Thom Calandra, editor in chief, CBS MarketWatchIn
The Biotech Investor,
San Francisco Chronicle biotechnology reporter Tom Abate explains the science, finances, time ho
You come away understanding that some human decisions played a role, this was not inevitable, though there were structural forces at work, too. Twists and turns with the irony that only a true story can release.A page turner! How does a normal, over privileged, high achieving young adult become an international criminal? What was the tipping point in this situation? A story more common than you think, we have the opportunity to hear it firsthand. Here, Jackson ridicules the corrupt "God/Devil" alliance and the underlying "Good Cop/Bad Cop" mentality Christians teach. 47 bottom)I wish there were more specific personal examples from his personal trading career. This book can be dry at times (text book style dictation), but the best part for me personally was the last chapter with the future predictions by Condocet in 1793. There are so many great natural recommendations in this book, I think that it is a must read for all new mothers!!! There are definately too many doctors that just want to give harmful presciption meds for so many of the symptoms after giving birth, that can easily be treated with a more natural approach. I find this to be very disappointing, for I am a major fan of Socrates and upon first glance at the length of his section in comparison to the others, I was ecstatic. A
But for those willing to brave the new world of biotechnology, this is a good place to start. His advice is appropriately cautious; he suggests putting no more than 20% of a portfolio in biotechnology, and waiting until a company is in hailing distance of profitability before investing. From Publishers Weekly With the population aging and eager for medical innovations, the market for biotechnology is vast. Abate, a biotechnology and health care reporter for the San Francisco Chronicle, provides an overview of each sector of the biotechnology industry and the leading companies in it, tells where to find up-to-date information on the scientific and medical developments that drive the market, and explains how to evaluate the financial prospects of the often shaky start-ups that crowd the field. This informative and well-written primer will help individual investors navigate the treacherous terrain of biotech stocks. But for investors looking at biotech firms, it can be a minefield: before a company’s brilliant ideas pan out a
No comments:
Post a Comment